Itaconix Revenue Guidance Raised as Eagle Eye Beats on ARR
Itaconix (ITX) raised 2026 revenue guidance to at least $14.8m from $13.3m after H1 revenues rose 72% to $8.3m. It expects 2026 gross margin of 36% and said guidance supports breakeven and investment. Eagle Eye (EYE) reported FY26 results ahead of expectations, with ARR up 31% to £44.5m. Alumasc (ALU) suspended CEO Pamela Bingham and trimmed forecasts.
How this was made

The 30-second read
Why it matters
ITX’s raised 2026 revenue guidance and improving gross margin outlook are likely to support valuation. EYE’s ARR growth excluding a lost customer and new contract wins support resilience. ALU’s CEO suspension and forecast trimming increase uncertainty and downside risk.
Market read
Traders can act on three distinct catalysts: ITX guidance lift, EYE beat with ARR growth despite churn, and ALU CEO suspension with forecast cuts.
What to watch
The article cites gross margin and EBITDA run-rate expectations but provides limited detail on cash conversion, working capital, and the investigation’s scope for ALU, which can dominate near-term price action.
Background
The piece is a cross-section of UK small-cap movers: guidance and recurring revenue updates for Itaconix and Eagle Eye, and a governance disruption for Alumasc, plus several other minor movers.
Ticker impact
Eagle Eye reported FY26 results ahead of expectations, with annualised recurring revenues up 31% and underlying ARR up 29% excluding a lost customer.
Moderately positive bias, with volatility around FY27 revenue conversion from new US wins and OEM partnership contracts.
The text includes concrete ARR/retention and new contract ARR expectations, but it does not quantify total FY26 revenue or provide guidance for FY27 beyond expected material revenue timing.
Market effects
Signals improving demand and margin trajectory in sustainable additives (ITX) and resilience in AI software recurring revenue (EYE), while construction products faces governance and order-timing headwinds (ALU).
UK AIM and LSE small-cap sentiment is mixed, with notable single-name moves tied to guidance, customer churn, and management actions.
Limited direct global spillover; primarily affects UK small-cap risk appetite and sector read-through for recurring-revenue and building-products investors.
Counterpoint
Raised guidance and ARR growth may still be fragile if customer wins and OEM contract revenue do not convert as expected into FY27, while ALU’s forecast trim could be partly conservative ahead of investigation findings.
Key entities
- issuerItaconix
Raised 2026 revenue guidance to at least $14.8m and reported H1 revenues up 72% to $8.3m.
- issuerEagle Eye Solutions
Reported FY26 results ahead of expectations, with annualised recurring revenues up 31% and underlying ARR up 29% excluding a lost customer.
- issuerAlumasc
Suspended CEO Pamela Bingham, launched an investigation, and trimmed FY26 revenue and pre-tax profit forecasts.

